Accelerating projects in
Clinical Research and
Market Access in
Emerging Markets

Play Video

A WORD FROM OUR CEO, SARA TYLOSKY:

“We bring our medical associates and alliances together for our client’s successful outcomes – all in a patient-centric way. Latin American is a region of 660 million people and it is a land of opportunity for clinical research and market access with an epidemiological profile resembling that of the Unites States – as well as diversity profiles when sought. Navigating the unique cultural and logistical challenges of Latin American and emerging markets is our specialty. Let’s brainstorm today.”

Sara Tylosky CEO Farmacon Global

WHAT FARMACON CAN DO FOR YOU:

Farmacon Global’s strategic solutions accelerate clinical trials and market access in emerging markets – such as Latin America – through our on-the-ground medical associates and alliances, where every patient and every community counts… all to the benefit of our clients’ successful outcomes.

DIA Global Conference 2022

“As more CRO’s and those responsible for today’s clinical trials grapple with sudden changes in the landscape – from budget-consuming delays to challenging patient enrollment

Read More »

Linkedin News

Newsletter by Email